Pathology
 |
|
26 june 2020 16:30:32 |
| Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patients (BMC Infectious Diseases) |
|
Tweet This study aimed to assess the pharmacokinetic profile of 150 mg rifabutin (RBT) taken every other day (every 48 h) versus 300 mg RBT taken every other day (E.O.D), both in combination with lopinavir/ritonavir... |
| 306 viewsCategory: Immunology, Pathology |
 Global molecular diversity of RSV – the “INFORM RSV” study (BMC Infectious Diseases)Tick-borne encephalitis (TBE) cases are not random: explaining trend, low- and high-frequency oscillations based on the Austrian TBE time series (BMC Infectious Diseases) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
